| Date | Form | Description | Docs | XBRL | Pages |
| 01/16/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/16/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/16/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/16/24 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
2 | |
| 01/16/24 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
25 | |
| 01/16/24 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
46 |
| 12/07/23 | 8-K | Current report filing |
|
|
5 |
| 11/02/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 10/11/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/06/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
19 |
Latest News & Events
Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Read More...Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th
Read More...Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
Read More...